Biological Approvals by Year
A collection of biological approval information organized by year and regulatory authorities.
Recommend0 recommendationsPublished in US National Health Agency Sources
Related Articles
KFF Health News’ ‘What the Health?’: American Health Gets a Pink Slip
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health…
5 Essential Frameworks for Preventing Violent Child Death
The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.
2025 Proposed CMS Rules – What’s in the Rules for RHCs & How You Can Get Involved in Regulatory Advocacy
– Thursday, August 15 at 2 pm Eastern. The National Association of Rural Health Clinics (NARHC) will host the free webinar with details on the recently released Centers for Medicare […]
The post 2025 Proposed CMS Rules – What’s in the Rules for RHCs & How You Can Get Involved in Regulatory Advocacy appeared first on Pennsylvania Office of Rural Health.
2025 Proposed CMS Rules – What’s in the Rules for RHCs & How You Can Get Involved in Regulatory Advocacy
– Thursday, August 15 at 2 pm Eastern. The National Association of Rural Health Clinics (NARHC) will host the free webinar with details on the recently released Centers for Medicare […]
The post 2025 Proposed CMS Rules – What’s in the Rules for RHCs & How You Can Get Involved in Regulatory Advocacy appeared first on Pennsylvania Office of Rural Health.
FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision
The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with …
The post FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision appeared first on Salud America.